The UK government has invested £260 million into diagnostics and treatment research in the NHS. £200 million will be used to improve access to NHS data through Trusted Research Environments and digital clinical trial services. This will not only aid in better research, but also mean that the NHS will be able to push out new life-saving treatments faster and improve patient care.
A further £60 million will go toward expanding the UK’s life sciences manufacturing by ââsupporting commercial-scale investments for innovative products and devices.
Secretary of State for Health and Social Care, Sajid Javid said: “NHS data is making the whole world safer and healthier and has been vital in saving thousands of lives during the COVID-19 pandemic.
“This funding will ensure the UK can continue to help researchers access NHS data securely so patients can benefit from more innovative treatments faster. I’m absolutely committed to boosting the UK’s position as a world-leading research centre, transforming our health service and ensuring the NHS continues to deliver excellent care for patients.”
Up to £200 million will come from the Department for Business, Energy and Industrial Strategy (BEIS) and the Department of Health and Social Care (DHSC) and the funding for manufacturing investments will be distributed through the Life Sciences Innovative Manufacturing Fund (LSIMF), the successor to the Medicines and Diagnostics Manufacturing Transformation Fund (MDMTF) which has been established to grow and strengthen the UK’s medicines and diagnostics manufacturing industry.